Design of Treatment Trials for Functional Gastrointestinal Disorders

Irvine, E. Jan, Tack, Jan, Crowell, Michael D., Gwee, Kok Ann, Ke, Meiyun, Schmulson, Max J., Whitehead, William E., Spiegel, Brennan·2016·Gastroenterology
DOI 10.1053/j.gastro.2016.02.010

Cited by (550)

Items 101–200 of 550

  1. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome – A randomized controlled trial with primary care physicians
    Paul Enck, Kurt Zimmermann, G. Menke, Stefan A Müller-Lissner, Ute Martens, Sibylle Klosterhalfen · 2008 · Neurogastroenterology & Motility
  2. Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) · 2016 · EFSA Journal
  3. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
    Goodoory, Vivek C., Khasawneh, Mais, Black, Christopher J., Quigley, Eamonn M.M., Moayyedi, Paul, Ford, Alexander C. · 2023 · Gastroenterology
  4. Design of Clinical Trials Evaluating Dietary Interventions in Patients With Functional Gastrointestinal Disorders
    Chu K Yao, Peter R. Gibson, Susan Shepherd · 2013 · The American Journal of Gastroenterology
  5. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome
    Guillaume Pineton de Chambrun, Christel Neut, Amélie Chau, Murielle Cazaubiel, Fanny Pélerin, Peter Jüsten, Pierre Desreumaux · 2014 · Digestive and Liver Disease
  6. The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
    van der Schoot, Alice, Drysdale, Candice, Whelan, Kevin, Dimidi, Eirini · 2022 · The American Journal of Clinical Nutrition
  7. A meta‐analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome
    Dorn, S. D., Kaptchuk, T. J., Park, J. B., Nguyen, L. T., Canenguez, K., Nam, B. H., Woods, K. B., Conboy, L. A., Stason, W. B., Lembo, A. J. · 2007 · Neurogastroenterology & Motility
  8. A Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of 0.5 mg and 1 mg Alosetron in Women With Severe Diarrhea-predominant IBS
    Richard A. Krause, Vanessa Z. Ameen, Susan Gordon, Marquita A. West, Amy T. Heath, Teresa L. Perschy, Eric G. Carter · 2007 · The American Journal of Gastroenterology
  9. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial
    Flik, Carla E, Laan, Wijnand, Zuithoff, Nicolaas P A, van Rood, Yanda R, Smout, André J P M, Weusten, Bas L A M, Whorwell, Peter J, de Wit, Niek J · 2019 · The Lancet Gastroenterology & Hepatology
  10. Characterization of Health Related Quality of Life (HRQOL) for Patients With Functional Bowel Disorder (FBD) and Its Response to Treatment
    Douglas A. Drossman, Carolyn Blank Morris, Yuming Hu, Brenda B. Toner, Nicholas E. Diamant, William E. Whitehead, Christine Boag Dalton, Jane Leserman, Donald L. Patrick, Shrikant I. Bangdiwala · 2007 · The American Journal of Gastroenterology
  11. Treatment of Functional Dyspepsia with a Herbal Preparation
    Ahmed Madisch, Gerald Holtmann, Gunthild Mayr, Bettina R. Vinson, J. Hotz · 2004 · Digestion
  12. Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial
    Cesare Cremon, Simone Guglielmetti, Giorgio Gargari, Valentina Taverniti, Anna Maria Castellazzi, Chiara Valsecchi, Sara Carlotta Tagliacarne, Walter Fiore, Massimo Bellini, Lorenzo Bertani et al. · 2017 · United European Gastroenterology Journal
  13. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome
    Ljótsson, Brjánn, Hedman, Erik, Lindfors, Perjohan, Hursti, Timo, Lindefors, Nils, Andersson, Gerhard, Rück, Christian · 2011 · Behaviour Research and Therapy
  14. International consensus statement on microbiome testing in clinical practice
    Serena Porcari, Benjamin Harvey Mullish, Francesco Asnicar, Siew C. Ng, Liping Zhao, Richard Hansen, Paul William O’Toole, Jeroen Raes, Georgina Louise Hold, Lorenza Putignani et al. · 2024 · The Lancet. Gastroenterology & hepatology
  15. Dose finding study of mosapride in functional dyspepsia: a placebo‐controlled, randomized study
    B. Hallerbäck, Gilles Bommelaer, Eva Bredberg, M. Campbell, Magnus Hellblom, K. Lauritsen, MARTIN WIENBECK, L. ‐L. Holmgren · 2002 · Alimentary Pharmacology & Therapeutics
  16. Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale
    Brennan Mason Ross Spiegel, Roger R. Bolus, Lucinda A. Harris, Susan L. Lucak, Bruce D. Naliboff, Eric Esrailian, William D. Chey, Anthony J Lembo, Hetal A. Karsan, Kirsten Tillisch et al. · 2009 · Alimentary Pharmacology & Therapeutics
  17. A dose‐ranging, placebo‐controlled, randomized trial of alosetron in patients with functional dyspepsia
    Nicholas Joseph Talley, S. V. VAN ZANTEN, L. R. Saez, George Earl Dukes, Teresa L. Perschy, M. Heath, Christi S. Kleoudis, Allen Wayne Mangel · 2001 · Alimentary Pharmacology & Therapeutics
  18. The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence
    Joost P. Algera, Esther Colomier, Magnus Simrén · 2019 · Nutrients
  19. Treatment of Diarrhea-Predominant Irritable Bowel Syndrome with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Trial
    Wai K. Leung, Justin CY Wu, SM Liang, LS Chan, Francis K.L. Chan, He Xie, Sara S. L. Fung, Aric Josun Hui, Vincent WS Wong, Chun‐Tao Che et al. · 2006 · The American Journal of Gastroenterology
  20. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3
    Dirk Haller, Jean‐Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir‐Wijnkoop · 2010 · Journal of Nutrition
  21. Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
    S. J. O. Veldhuyzen van Zanten, Naoki Chiba, David Armstrong, Alan N. Barkun, Alan B.R. Thomson, Vijay Mann, Sergio Escobedo, Bijan Chakraborty, Krista Nevin · 2006 · Alimentary Pharmacology & Therapeutics
  22. Randomised controlled trial of mesalazine in IBS
    Giovanni Barbara, Cesare Cremon, Vito Annese, Guido Basilisco, Franco Bazzoli, Massimo Bellini, A. Benedetti, L. Benini, Fabrizio Bossa, P. Buldrini et al. · 2014 · Gut
  23. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia
    B. ADAM, Tobias Liebregts, K Saadat-Gilani, Bettina R. Vinson, Gerald Holtmann · 2005 · Alimentary Pharmacology & Therapeutics
  24. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients
    Leonilde Bonfrate, Domenica Maria Di Palo, Giuseppe Celano, Adelin Albert, Paola Vitellio, Maria De Angelis, Marco Gobbetti, Piero Portincasa · 2020 · European Journal of Clinical Investigation
  25. Evaluation of the Birmingham IBS symptom questionnaire
    Andrea K. Roalfe, Lesley Martine Roberts, Sue Wilson · 2008 · BMC Gastroenterology
  26. Tegaserod for the treatment of irritable bowel syndrome
    BW Evans, WK Clark, DJ Moore, Peter James Whorwell · 2004 · Cochrane Database of Systematic Reviews
  27. Sugar malabsorption in functional abdominal bloating: A pilot study on the long-term effect of dietary treatment
    Fernando Fernández‐Bañares, Mercè Rosinach, María Esteve, Montserrat Forné, Jorge Carlos Espinós, Josep Maria Viver · 2006 · Clinical Nutrition
  28. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial
    Weizman, Zvi, Abu-Abed, Jaber, Binsztok, Mauricio · 2016 · The Journal of Pediatrics
  29. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study
    Guyonnet, Denis, Schlumberger, Armelle, Mhamdi, Leila, Jakob, Stefan, Chassany, Olivier · 2009 · British Journal of Nutrition
  30. Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea
    Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro Nakashima, Kei Matsueda · 2013 · Clinical Gastroenterology and Hepatology
  31. Prevalence and Symptom Pattern of Pathologic Esophageal Acid Reflux in Patients With Functional Dyspepsia Based on the Rome III Criteria
    Yinglian Xiao, Sui Peng, Jin Tao, Anjiang Wang, Jin-kun Lin, P. Hu, Minhu Chen · 2010 · The American Journal of Gastroenterology
  32. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence
    Olafur Steinn Palsson · 2015 · American Journal of Clinical Hypnosis
  33. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome
    Jørgen Valeur, Milada Cvancarova Småstuen, Torunn Knudsen, Gülen Arslan Lied, Arne Gustav Røseth · 2018 · Digestive Diseases and Sciences
  34. Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo‐controlled and dose‐finding study
    S. Fukudo, M. Hongo, H. Kaneko, R. Ueno · 2011 · Neurogastroenterology and Motility
  35. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?
    Sebastian Haag, W Senf, Sefik Tagay, Matthias Langkafel, Ute Braun-Lang, Alexander P. Pietsch, Gereon Heuft, Nicholas Joseph Talley, Gerald Holtmann · 2007 · Alimentary Pharmacology & Therapeutics
  36. Subject's Global Assessment of Relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials
    Müller-Lissner, S · 2003 · Journal of Clinical Epidemiology
  37. Primary Endpoints for Irritable Bowel Syndrome Trials: A Review of Performance of Endpoints
    Michael Camilleri, Allen Wayne Mangel, Sheri E. Fehnel, Douglas A. Drossman, Emeran A. Mayer, Nicholas J. Talley · 2007 · Clinical Gastroenterology and Hepatology
  38. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double‐blind, randomized, placebo‐controlled study
    Susanne Kienzle-Horn, J.‐M. VIX, Chris Schuijt, Hubertus Peil, Chris Jordan, Michael A. Kamm · 2006 · Alimentary Pharmacology & Therapeutics
  39. Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial
    van Zanten, Sander Veldhuyzen, Armstrong, David, Chiba, Naoki, Flook, Nigel, White, Robert J, Chakraborty, Bijan, Gasco, Ally · 2006 · The American Journal of Gastroenterology
  40. A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome
    Lesley Martine Roberts, Deborah McCahon, ROGER L. HOLDER, Sue Wilson, Richard F. Hobbs · 2013 · BMC Gastroenterology
  41. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study
    Michel C. Dapoigny · 2012 · World Journal of Gastroenterology
  42. Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome
    Corazziari, E., Bytzer, P., Delvaux, M., Holtmann, G., Malagelada, J. R., Morris, J., Muller‐Lissner, S., Spiller, R. C., Tack, J., Whorwell, P. J. · 2003 · Alimentary Pharmacology & Therapeutics
  43. Bioecologic Control of the Gastrointestinal Tract: The Role of Flora and Supplemented Probiotics and Synbiotics
    Stig Bengmark · 2005 · Gastroenterology Clinics of North America
  44. Drug treatment of functional dyspepsia
    Klaus E. Mönkemüller · 2006 · World Journal of Gastroenterology
  45. A Pilot Study of the Use of Guided Imagery for the Treatment of Recurrent Abdominal Pain in Children
    Thomas M. Ball, Daniel Shapiro, Cynthia J. Monheim, Joy A. Weydert · 2003 · Clinical Pediatrics
  46. Validation of Irritable Bowel Syndrome Global Improvement Scale: An Integrated Symptom End Point for Assessing Treatment Efficacy
    Susan Gordon, Vanessa Z. Ameen, Barbara Bagby, Britt Shahan, Priti M. Jhingran, Eric Carter · 2003 · Digestive Diseases and Sciences
  47. Randomized clinical trial: Effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome
    C Stevenson, Renée Blaauw, Ernst Fredericks, Janicke Visser, Saartjie Roux · 2014 · Nutrition
  48. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Michelle Bosman, S. Elsenbruch, M. Corsetti, J. Tack, M. Simrén, B. Winkens, Thimo Boumans, A. Masclee, D. Keszthelyi · 2021 · The Lancet Gastroenterology and Hepatology
  49. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis
    Ortiz-Lucas, María, Aurelio, Tobias, Saz, Pablo, Sebastián, Juan José · 2013 · Revista Española de Enfermedades Digestivas
  50. The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study
    Toshihiro Ohtsu, Atsushi Takagi, Naomi Uemura, Kazuhiko Inoue, Hisakuni Sekino, Akihiro Kawashima, Masayuki Uchida, Yasuhiro Koga · 2017 · Digestion
  51. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets
    Michael Camilleri, Nicholas J. Talley · 2004 · Neurogastroenterology & Motility
  52. Rapid Response to Cognitive Behavior Therapy Predicts Treatment Outcome in Patients With Irritable Bowel Syndrome
    Lackner, Jeffrey M., Gudleski, Gregory D., Keefer, Laurie, Krasner, Susan S., Powell, Cathrine, Katz, Leonard A. · 2010 · Clinical Gastroenterology and Hepatology
  53. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome
    Laura Rindom Krogsgaard, Malene Lyngesen, Peter M. Bytzer · 2017 · Alimentary Pharmacology & Therapeutics
  54. Review article: endpoints used in functional dyspepsia drug therapy trials
    Daphne Ang, Nicholas J. Talley, Magnus Simrén, Pieter Janssen, Guy E. Boeckxstaens, Jan F. Tack · 2011 · Alimentary Pharmacology & Therapeutics
  55. Exposure and mindfulness based therapy for irritable bowel syndrome - An open pilot study
    Ljótsson, Brjánn, Andréewitch, Sergej, Hedman, Erik, Rück, Christian, Andersson, Gerhard, Lindefors, Nils · 2010 · Journal of Behavior Therapy and Experimental Psychiatry
  56. Enriched Enrollment Randomized Withdrawal Trial Designs of Analgesics
    Nathaniel P. Katz · 2009 · Clinical Journal of Pain
  57. Clinical Trial on the Efficacy of a New Symbiotic Formulation, Flortec, in Patients With Irritable Bowel Syndrome: A Multicenter, Randomized Study
    Andriulli, Angelo, Neri, Matteo, Loguercio, Carmelina, Terreni, Natalia, Merla, Antonio, Cardarella, Maria Pia, Federico, Alessandro, Chilovi, Fausto, Milandri, Gian Luigi, De Bona, Michela et al. · 2008 · Journal of Clinical Gastroenterology
  58. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis , BB-12 ® , on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial
    Eskesen, Dorte, Jespersen, Lillian, Michelsen, Birgit, Whorwell, Peter J., Müller-Lissner, Stefan, Morberg, Cathrine M. · 2015 · British Journal of Nutrition
  59. A Novel Treatment for Constipation-Predominant Irritable Bowel Syndrome Using Padma®Lax, a Tibetan Herbal Formula
    Sarah Sallon, Eran Ben‐Arye, Roni Davidson, Haim Shapiro, Gary Michael Ginsberg, Moshe Ligumsky · 2002 · Digestion
  60. Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report
    Brennan Mason Ross Spiegel, Michael Camilleri, Roger R. Bolus, Viola Andresen, William D. Chey, Sheri E. Fehnel, Allen Wayne Mangel, Nicholas J. Talley, William E. Whitehead · 2009 · Gastroenterology
  61. Developing Valid and Reliable Health Utilities in Irritable Bowel Syndrome: Results From the IBS PROOF Cohort
    Brennan Mason Ross Spiegel, Lucinda A. Harris, Susan L. Lucak, Emeran A. Mayer, Bruce D. Naliboff, Roger R. Bolus, Eric Esrailian, William D. Chey, Anthony J Lembo, Hetal A. Karsan et al. · 2009 · The American Journal of Gastroenterology
  62. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome ‐ a randomized, double‐blind, placebo‐controlled study
    Tibor Wittmann, Leszek Paradowski, Philippe R. Ducrotte, Lionel P. Bueno, Marie-Christine Andro-Delestrain · 2010 · Alimentary Pharmacology & Therapeutics
  63. Challenges to the Therapeutic Pipeline for Irritable Bowel Syndrome: End Points and Regulatory Hurdles
    Michael Camilleri, Lin Chang · 2008 · Gastroenterology
  64. Alosetron and irritable bowel syndrome
    Emeran A. Mayer, Sylvie Bradesi · 2003 · Expert Opinion on Pharmacotherapy
  65. H2‐receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta‐analysis of randomized controlled clinical trials
    Heather A. Redstone, Nicholas James Barrowman, S. J. O. Veldhuyzen Van Zanten · 2001 · Alimentary Pharmacology & Therapeutics
  66. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness
    Simon Robert Knowles, David Austin, Suresh Sivanesan, Jason A. Tye–Din, Chris Leung, Jarrad Wilson, David Jonathan Castle, Michael A. Kamm, Finlay Macrae, Geoff S. Hebbard · 2016 · Psychology Health & Medicine
  67. Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled trials
    Anthony J Lembo, Kevin W. Olden, Vanessa Z. Ameen, Susan L. Gordon, Amy T. Heath, Eric G. Carter · 2004 · Clinical Gastroenterology and Hepatology
  68. The methodological quality of trials affects estimates of treatment efficacy in functional (non‐ulcer) dyspepsia
    N. S. Abraham, Paul Moayyedi, B. Daniels, S. J. O. Veldhuyzen van Zanten · 2004 · Alimentary Pharmacology & Therapeutics
  69. Brief hypnotherapeutic–behavioral intervention for functional abdominal pain and irritable bowel syndrome in childhood: a randomized controlled trial
    Marco Daniel Gulewitsch, Judith Müller, Martin Hautzinger, Angelika Anita Schlarb · 2013 · European Journal of Pediatrics
  70. Incorporating patients’ views and experiences of life with IBS in the development of an evidence based self-help guidebook
    Anne P Kennedy, Andrew Robinson, Anne E. Rogers · 2003 · Patient Education and Counseling
  71. Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs
    Oerlemans, Simone, van Cranenburgh, Oda, Herremans, Pieter-Jan, Spreeuwenberg, Peter, van Dulmen, Sandra · 2011 · Journal of Psychosomatic Research
  72. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study
    Jin Young Yoon, Jae Myung Cha, Ju Kyoung Oh, Pei Lei Tan, Sae Hun Kim, Min Seob Kwak, Jung Won Jeon, Hyun Phil Shin · 2018 · Digestive Diseases and Sciences
  73. Responsiveness of quality of life measurements to change after reconstructive pelvic surgery
    Mary P. FitzGerald, Kim Kenton, Susan Shott, Linda T. Brubaker · 2001 · American Journal of Obstetrics and Gynecology
  74. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial
    Shinozaki, Masae, Kanazawa, Motoyori, Kano, Michiko, Endo, Yuka, Nakaya, Naoki, Hongo, Michio, Fukudo, Shin · 2010 · Applied Psychophysiology and Biofeedback
  75. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation
    Susanne Kienzle-Horn, Jean-Michel Vix, Chris Schuijt, Hubertus Peil, Chris Jordan, Michael A. Kamm · 2007 · Current Medical Research and Opinion
  76. Efficacy of dioctahedral smectite in treating patients of diarrhea‐predominant irritable bowel syndrome
    Full‐Young Chang, Ching‐Liang Lu, Chih‐Yen Chen, Jiing–Chyuan Luo · 2007 · Journal of Gastroenterology and Hepatology
  77. Assessing patient reported outcome measures: A practical guide for gastroenterologists
    Laith Alrubaiy, Hayley Anne Hutchings, John Gordon Williams · 2014 · United European Gastroenterology Journal
  78. Quality of life measures in irritable bowel syndrome
    R. Wong, D. Drossman · 2010 · Expert Review of Gastroenterology & Hepatology
  79. Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea
    William D. Chey, Brooks D. Cash · 2005 · Expert Opinion on Investigational Drugs
  80. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up
    Lackner, Jeffrey M., Jaccard, James, Radziwon, Christopher D., Firth, Rebecca S., Gudleski, Gregory D., Hamilton, Frank, Katz, Leonard A., Keefer, Laurie, Krasner, Susan S., Ma, Chang-Xing et al. · 2019 · American Journal of Gastroenterology
  81. Tegaserod for Female Patients Suffering From IBS With Mixed Bowel Habits or Constipation: A Randomized Controlled Trial
    William D. Chey, Pierre Paré, Andrea Viegas, Gregory Ligozio, Michael A. Shetzline · 2008 · The American Journal of Gastroenterology
  82. Negative Impact of Disorders of Gut-Brain Interaction on Health-Related Quality of Life: Results From the Rome Foundation Global Epidemiology Survey
    Simon Robert Knowles, David Skvarc, Alexander Charles Ford, Olafur Steinn Palsson, Shrikant I. Bangdiwala, Ami David Sperber, Antonina A Mikocka‐Walus · 2022 · Gastroenterology
  83. Adequate Relief in a Treatment Trial With IBS Patients: A Prospective Assessment
    Maria C. Passos, Anthony J Lembo, Lisa Ann Conboy, Ted Jack Kaptchuk, John M Kelly, Mary T. Quilty, Catherine E. Kerr, Eric Jacobson, Rong Hu, Elizabeth Friedlander et al. · 2009 · The American Journal of Gastroenterology
  84. Colonic Mucosal Immune Activity in Irritable Bowel Syndrome: Comparison with Healthy Controls and Patients with Ulcerative Colitis
    Ji Yong Ahn, Kyung Hun Lee, Chang Hwan Choi, Ju Wan Kim, Hyun Woong Lee, Jeong Wook Kim, Mi Kyung Kim, Gui Young Kwon, Seungbong Han, Seong‐Eun Kim et al. · 2013 · Digestive Diseases and Sciences
  85. There are some benefits for eradicating Helicobacter pylori in patients with non‐ulcer dyspepsia
    Stanislas Bruley des Varannes, Jean–François Fléjou, Raymond Colin, Mohamed Zaïm, A. Meunier, Claude Bidaut-Mazel · 2001 · Alimentary Pharmacology & Therapeutics
  86. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
    Łukasz Krokowicz, Zoran Stojčev, B Kaczmarek, Wojciech Kociemba, Elżbieta Kaczmarek, Jarosław Walkowiak, Piotr Krokowicz, Michał Drews, Tomasz Banasiewicz · 2013 · International Journal of Colorectal Disease
  87. Rationale for using serotonergic agents to treat irritable bowel syndrome
    Danial E. Baker · 2005 · American Journal of Health-System Pharmacy
  88. A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome
    Varol Tunalı, Naci̇ye Çiğdem Arslan, Beyza Hilal Ermiş, Gözde Derviş Hakim, Aycan Gündoğdu, Mehmet Hora, Özkan Ufuk Nalbantoğlu · 2024 · The American Journal of Gastroenterology
  89. Saccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
    Amélie Cayzeele Decherf, Fanny Pélerin, Sébastien Leuillet, Benoit Douillard, Béatrice Housez, Murielle Cazaubiel, Gunnard K. Jacobson, Peter Jüsten, Pierre Desreumaux · 2017 · World Journal of Gastroenterology
  90. Efficacy of different probiotic protocols in irritable bowel syndrome
    Liang Ding, Longgui Ning, Guoqiang Xu · 2019 · Medicine
  91. A randomized controlled trial of imipramine in patients with irritable bowel syndrome
    Heitham A. Abdul-Baki, Ihab I. El Hajj, Lara M. El-Zahabi, Cecilio R. Azar, Elie G. Aoun, Assaad M. Skoury, Hani F. Chaar, Ala I. Sharara · 2009 · World Journal of Gastroenterology
  92. Efficacy and safety of Gelsectan for diarrhoea‐predominant irritable bowel syndrome: A randomised, crossover clinical trial
    Anca Victorita Trifan, Ovidiu Burta, Nicoleta Tiucă, Diana Corina Petrisor, A Lenghel, Javier Santos · 2019 · United European Gastroenterology Journal
  93. Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol – a randomized, double‐blind, placebo‐controlled study
    Olivier Chassany, Bruno L. Bonaz, Stanislas Bruley des Varannes, Lionel P. Bueno, Guillaume A. Cargill, Benoît Coffin, Philippe R. Ducrotte, Veronique Grange · 2007 · Alimentary Pharmacology & Therapeutics
  94. Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Zhou, Qian, Lei, Xingxing, Fu, Shunlian, Liu, Pan, Long, Cong, Wang, Yanmei, Li, Zinan, Xie, Qian, Chen, Qiu · 2023 · Diabetology & Metabolic Syndrome
  95. Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics
    Rossella Turco, Silvia Salvatore, Erasmo Miele, Claudio Romano, Gian Luigi Marseglia, Annamaria Staiano · 2018 · The Italian Journal of Pediatrics/Italian journal of pediatrics
  96. Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China
    Xiaohua Hou, Shengliang Chen, Yali Zhang, Weihong Sha, Xiaofeng Yu, Hesham Elsawah, Afifi Fahmy Afifi, Hisham R El‐Khayat, Alaa Nouh, Mohamed Fathalla Hassan et al. · 2014 · Clinical Drug Investigation
  97. Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
    Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R. van Rood, André J.P.M. Smout, Niek J. de Wit · 2017 · World Journal of Gastroenterology
  98. Different segmental transit times in patients with irritable bowel syndrome and “normal” colonic transit time: is there a correlation with symptoms?
    Michel L. Bouchoucha, Ghislain J. Devroede, Etienne Danquechin Dorval, Alain Faye, Pierre Arhan, Michel Arsac · 2006 · Techniques in Coloproctology
  99. Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial
    Qi Zhang, Guang Li, Wen Zhao, Limian Zhou, Xiaoyu Zhang, Jingjing He, Xiaoxu Zhang, Yinghua Liu, Chengying Zhang, Chengying Zhang et al. · 2024 · Nature Communications
  100. Consenso Latinoamericano de Estreñimiento Crónico
    Max Schmulson Wasserman, Carlos Fernando de Magalhães Francisconi, Kevin W. Olden, L. Aguilar-Paiz, Luis María Bustos-Fernández, Henry Cohen, Maria do Carmo Friche Passos, Marina Alejandra González-Martínez, Beatriz Iade, Guido Iantorno et al. · 2008 · Gastroenterología y Hepatología